Blood clotting in children with leukemia
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at blood clotting problems in children with acute lymphoblastic leukemia (ALL) who are being treated with the ALLTogether1 protocol. It aims to understand how the disease and its treatment affect clotting, which could help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 17 years old at diagnosis
- You have been diagnosed with acute lymphoblastic leukemia (ALL) in Sweden
- You are being treated with the ALLTogether1 protocol
- You and your parents (if you're under 18) agree to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the gut microbiome (tiny organisms in the gut) and metabolome (small chemicals in the body) in children and teens with newly diagnosed ALL. It may help researchers understand what is happening in the body early in treatment and could guide future, more personalized care.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
This trial tests a standard chemotherapy regimen for people aged 18 to 50 with a type of leukemia called Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). It aims to see how well the treatment works for this age group.
This study follows children and teens with newly diagnosed certain leukemia (ALL) and certain favorable brain tumors to learn best care and outcomes. It may help your team compare standard treatments and monitor health over time.
This study looks at a new score (SiAML) to predict bleeding and blood clot risks in people newly diagnosed with acute leukemia. It aims to help doctors better manage these risks compared to current tests.
This study looks at markers in the blood to understand why low red blood cell counts (anemia) can cause bleeding problems in people with certain leukemias. It may help find better ways to treat or prevent bleeding during early chemotherapy.
Hear when a new Acute Lymphoblastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.